BTMD

Biote Corp. Class A Common Stock (BTMD)

Stock · NASDAQ · Health Care

$1.11as of 10/16/2026

Price chart

Open in TradingView

Active signals

High Beta37.3%
200 SMA Touch0.0%
Resistance level
$2.18
Industry
Medicinal Chemicals and Botanical Products

BTMD Signal Track Record

How signals performed across all stocks →

What BTMD's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike43-1.2%47%
Bollinger Band Breakdown25-4.1%44%
Bollinger Band Breakout230.0%48%
200-Day Moving Average TouchActive now14-4.5%21%
Any 20-session window (baseline)-2.7%44%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About BTMD

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components develo…

Sector
Health Care
Industry
Medicinal Chemicals and Botanical Products
Employees
223

Fundamentals

1-day range
$1.08$1.14
Market cap
$61.26M
P/E (trailing)
6.81
P/E (forward)
2.41
EPS (trailing)
$0.11
Dividend yield
—
Beta
1.74
Avg. volume
220.1K
52-week range
$1$3.26
Next earnings: November 4, 2026 · EPS estimate $0.04confirmed

How Biote Corp. Class A Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$192.22MNet Income$27.05M (14%)SG&A$101.81M (53%)Other$57.38M (30%)Tax$5.99M (3%)BTMD

Source: 10-K filed Mar 13, 2026 · via SEC EDGAR / Finnhub

Operating Income$35.55M(18%)

Forecasts

5 analyst ratings

Buy 82%
Hold 18%
Sell 0%
1-year price forecast
High
$4
+262.0%
Median
$2.5
+126.2%
Low
$1.5
+35.7%

Biote Corp. Class A Common Stock Competitors

Chosen by industry and closest market cap.

  • BTMD
    Biote Corp. Class A Common Stock
    $1.09
    ▼ 2.25%
    Market cap $61.26MP/E 6.81
    $1$3.26
  • ISPR
    Ispire Technology Inc. Common Stock
    $1.35
    ▼ 6.25%
    Market cap $95.28MP/E —
    $1.01$3.87
  • FTLF
    FitLife Brands Inc. Common Stock
    $8.39
    ▼ 2.21%
    Market cap $95.88MP/E 12.92
    $8.5$20.15
  • NAII
    Natural Alternatives International Inc. Common Stock
    $1.15
    ▲ 2.68%
    Market cap $14.94MP/E —
    $1.08$4.96
  • MTEX
    Mannatech Incorporated Common Stock
    $7.13
    ▲ 0.00%
    Market cap $9.84MP/E —
    $3.8$12.45
  • BON
    Bon Natural Life Limited Class A Ordinary Shares
    $1.14
    ▲ 0.53%
    Market cap $8.86MP/E —
    $0.95$2.34
  • AKAN
    Akanda Corp. Common Shares
    $1.2
    ▼ 8.40%
    Market cap $2.90MP/E —
    $1.27$78.9

P/E shows — for peers not currently carrying a live signal of their own.

Insider Activity

Insider Actions →
Acquired
1.56M
Disposed
0

Institutional Ownership

March 31, 2026

Total shares held
14.84M
Total value held
$19.09M
Institutional holders
80
Top holders this quarter
  • Unknown4.55M
  • Unknown2.07M
  • Unknown1.74M
  • Unknown1.11M
  • Unknown697.9K
  • Unknown647.0K
  • Unknown615.7K
  • Unknown543.5K
  • Unknown272.4K
  • Unknown269.1K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.